Lack of awareness among future medical professionals about the risk of consuming hidden phosphate-containing processed food and drinks

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Shutto, Yoshiko ^a   Shimada, Michiko ^b   Kitajima, Maiko ^b   Yamabe, Hideaki ^b   Razzaque, Mohammed S ^c  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE; PHOSPHORIC ACID; SUGAR;

ADULT; ARTICLE; BEVERAGE; CARBONATED BEVERAGE; EATING HABIT; FAST FOOD; FEMALE; FOOD; FOOD PROCESSING; HEALTH CARE PERSONNEL; HEALTH HAZARD; HUMAN; JAPAN; MALE; MEDICAL STUDENT; NURSING STUDENT; NUTRITIONAL HEALTH; RANDOM SAMPLE; ATTITUDE TO HEALTH; FEEDING BEHAVIOR; HEALTH CARE SURVEY; RISK FACTOR; STATISTICS;

ADULT; BEVERAGES; FAST FOODS; FEEDING BEHAVIOR; FEMALE; FOOD HABITS; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PHOSPHATES; RISK FACTORS; STUDENTS, MEDICAL; STUDENTS, NURSING; YOUNG ADULT;

EID: 84855290514     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029105     Document Type: Article

References (29)

1. Razzaque MS, (2011) Phosphate toxicity: new insights into an old problem. Clin Sci (Lond) 120: 91-97.
2. Econs MJ, (1999) New insights into the pathogenesis of inherited phosphate wasting disorders. Bone 25: 131-135.
3. Razzaque MS, (2011) Osteo-renal regulation of systemic phosphate metabolism. IUBMB Life 63: 240-247.
4. Snively CS, Gutierrez C, (2004) Chronic kidney disease: prevention and treatment of common complications. Am Fam Physician 70: 1921-1928.
5. Razzaque MS, (2009) The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol 5: 611-619.
6. Terai K, Nara H, Takakura K, Mizukami K, Sanagi M, et al. (2009) Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels. Br J Pharmacol 156: 1267-1278.
7. Razzaque MS, (2009) FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am J Physiol Renal Physiol 296: F470-476.
8. Ohnishi M, Razzaque MS, (2010) Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J 24: 3562-3571.
9. Razzaque MS, (2011) The dualistic role of vitamin D in vascular calcifications. Kidney Int 79: 708-714.
10. Ohnishi M, Nakatani T, Lanske B, Razzaque MS, (2009) In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels. Circ Cardiovasc Genet 2: 583-590.
11. Ohnishi M, Kato S, Razzaque MS, (2011) Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice. Biochem Biophys Res Commun doi:10.1016/j.bbrc.2011.1010.1076.
12. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, et al. (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16: 520-528.
13. Eddington H, Hoefield R, Sinha S, Chrysochou C, Lane B, et al. (2010) Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol 5: 2251-2257.
14. Kanbay M, Goldsmith D, Akcay A, Covic A, (2009) Phosphate- the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review. Blood Purif 27: 220-230.
15. Block G, Port FK, (2003) Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial 16: 140-147.
16. Hruska K, Mathew S, Lund R, Fang Y, Sugatani T, (2011) Cardiovascular risk factors in chronic kidney disease: does phosphate qualify? Kidney Int Suppl pp. S9-13.
17. Barsoum RS, (2006) Chronic kidney disease in the developing world. N Engl J Med 354: 997-999.
18. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, et al. (2009) Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 13: 621-630.
19. Tokunaga S, White IR, Frost C, Tanaka K, Kono S, et al. (2002) Green Tea Consumption and Serum Lipids and Lipoproteins in a Population of Healthy Workers in Japan. Ann Epidemiol 12: 157-165.
20. Honda M, Adachi M, (1989) Green tea consumption and meals-a case of junior high school in Sakado, Saitama. Jpn J Nutr 47: 241-249.
21. Haig A, (1889) Influence of phosphate of soda on the excretion of uric acid and some of the conditions which prevent its action. Med Chir Trans 72: 399-406.
22. Molony DA, Stephens BW, (2011) Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations. Adv Chronic Kidney Dis 18: 120-131.
23. Ahlenstiel T, Pape L, Ehrich JH, Kuhlmann MK, (2010) Self-adjustment of phosphate binder dose to meal phosphorus content improves management of hyperphosphataemia in children with chronic kidney disease. Nephrol Dial Transplant 25: 3241-3249.
24. Sigrist MK, Chiarelli G, Lim L, Levin A, (2009) Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review. J Ren Care 35 (Suppl 1): 71-78.
25. Ketteler M, Biggar PH, (2009) Dietary and pharmacological control of calcium and phosphate metabolism in predialysis stages of chronic kidney disease. Blood Purif 27: 345-349.
26. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS, (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12.
27. Razzaque MS, (2007) Does renal ageing affect survival? Ageing Res Rev 6: 211-222.
28. Antoniucci DM, Yamashita T, Portale AA, (2006) Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 91: 3144-3149.
29. Marraffa JM, Hui A, Stork CM, (2004) Severe hyperphosphatemia and hypocalcemia following the rectal administration of a phosphate-containing Fleet pediatric enema. Pediatr Emerg Care 20: 453-456.